|
Four initiatives from across Africa win share of global US$1 million Healthcare Innovation Award
|
03 February 2015 |
|
Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial
|
23 January 2015 |
|
New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine
|
17 December 2014 |
|
GSK statement on first phase 1 trial results of a candidate Ebola vaccine
|
26 November 2014 |
|
GSK commits further funding to advance bioelectronics research with creation of $5 million Innovation Challenge Fund
|
07 October 2014 |
|
GSK joins with research councils in UK and South Africa to tackle non-communicable diseases
|
10 September 2014 |
|
Ebola vaccine trials fast-tracked by international consortium
|
29 August 2014 |
|
Where do you start when developing a new medicine?
|
27 March 2014 |
|
GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
|
10 March 2014 |
|
Tafinlar® receives FDA Breakthrough Therapy designation for non-small cell lung cancer with BRAF mutation
|
14 January 2014 |